Jonas M den Heijer

9PUBLICATIONS
13CO-AUTHORS
Molecular targetsPharmacogenomicsToxicology (incl. clinical toxicology)NeurogeneticsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 17, 2023
A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator.

Jonas M den Heijer, Annelieke C Kruithof, Matthijs Moerland

|Mar 14, 2023
A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.

Jonas M den Heijer, Valerie C Cullen, Diana R Pereira

|Nov 07, 2022
A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease.

Eva Thijssen, Soma Makai-Bölöni, Emilie van Brummelen

|Jan 20, 2022
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009.

Eva Thijssen, Jonas den Heijer, David Puibert

|May 18, 2021
Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a Subgroup.

Justin M O'Sullivan, Jonas M den Heijer, Geert J Groeneveld

|May 03, 2021
Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines.

Jonas M den Heijer, Jules A A C Heuberger, Hemme Hijma

Pageof 2